Cassader, Maurizio

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms

Bugianesi, E., Gastaldelli, A., Vanni, E., Gambino, R., Cassader, M., Baldi, S., Ponti, V., Pagano, G., Ferrannini, E., & Rizzetto, M. (2005) · Diabetologia

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 770

Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials

Musso, G., Cassader, M., Rosina, F., & Gambino, R. (2012) · Diabetologia

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 661

Interactions Between Gut Microbiota and Host Metabolism Predisposing to Obesity and Diabetes

Musso, G., Gambino, R., & Cassader, M. (2011) · Annual Review of Medicine

Gut microbiota and healthAdipokines, Inflammation, and Metabolic Diseases

Cited by 598

Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis

Musso, G., Cassader, M., Paschetta, E., & Gambino, R. (2017) · JAMA Internal Medicine

Liver Disease Diagnosis and TreatmentLiver Diseases and Immunity

Cited by 449

Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis

Musso, G., Cassader, M., Paschetta, E., & Gambino, R. (2018) · Gastroenterology

Liver Disease Diagnosis and TreatmentLipid metabolism and biosynthesis

Cited by 332

An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects.

Pagano, G., Cavallo-Perin, P., Cassader, M., Bruno, A., Ozzello, A., Masciola, P., Dall'omo, A. M., & Imbimbo, B. (1983) · Journal of Clinical Investigation

Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic Diseases

Cited by 259

Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial

Bo, S., Ponzo, V., Ciccone, G., Evangelista, A., Saba, F., Goitre, I., Procopio, M., Pagano, G. F., Cassader, M., & Gambino, R. (2016) · Pharmacological Research

Sirtuins and Resveratrol in MedicineNatural Antidiabetic Agents Studies

Cited by 146

Nonalcoholic steatohepatitis versus steatosis: adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism

Musso, G., Cassader, M., De Michieli, F., Rosina, F., Orlandi, F., & Gambino, R. (2012) · Hepatology

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 126

Prolonged saturated fat–induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver

Musso, G., Gambino, R., Pacini, G., De Michieli, F., & Cassader, M. (2009) · The American Journal of Clinical Nutrition

Liver Disease Diagnosis and TreatmentAdipokines, Inflammation, and Metabolic Diseases

Cited by 107

Different Serum Free Fatty Acid Profiles in NAFLD Subjects and Healthy Controls after Oral Fat Load

Gambino, R., Bugianesi, E., Rosso, C., Mezzabotta, L., Pinach, S., Alemanno, N., Saba, F., & Cassader, M. (2016) · International Journal of Molecular Sciences

Liver Disease Diagnosis and TreatmentFatty Acid Research and Health

Cited by 101

Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression

Musso, G., Sircana, A., Saba, F., Cassader, M., & Gambino, R. (2020) · PLOS Medicine

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 61

Contributors to the obesity and hyperglycemia epidemics. A prospective study in a population-based cohort

Bo, S., Ciccone, G., Durazzo, M., Ghinamo, L., Villois, P., Canil, S., Gambino, R., Cassader, M., Gentile, L., & Cavallo-Perin, P. (2011) · International Journal of Obesity

Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 61

Insulin resistance in Graves' disease: a quantitative in‐vivo evaluation

CAVALLO‐PERIN, P., BRUNO, A., BOINE, L., CASSADER, M., LENTI, G., & PAGANO, G. (1988) · European Journal of Clinical Investigation

Thyroid Disorders and TreatmentsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 58

Effect of phospholipid curcumin Meriva on liver histology and kidney disease in nonalcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial

Musso, G., Pinach, S., Mariano, F., Saba, F., De Michieli, F., Framarin, L., Berrutti, M., Paschetta, E., Parente, R., Lizet Castillo, Y., et al. (2025) · Hepatology

Curcumin's Biomedical ApplicationsLiver Disease Diagnosis and Treatment

Cited by 31

Pioglitazone for advanced fibrosis in nonalcoholic steatohepatitis: new evidence, new challenges

Musso, G., Cassader, M., Paschetta, E., & Gambino, R. (2017) · Hepatology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 26

Serum glucose, insulin and C-peptide response to oral glucose after intravenous administration of hydrocortisone and methylprednisolone in man

Bruno, A., Carucci, P., Cassader, M., Cavallo-Perin, P., Gruden, G., Olivetti, C., & Pagano, G. (1994) · European Journal of Clinical Pharmacology

Adrenal Hormones and DisordersPancreatic function and diabetes

Cited by 13